SOPHIA LEONARD-BURNS: Open Payments
NPI 1568549715 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 73 payments from 14 companies in 2025. Trend: 2023 $1,401 · 2024 $1,917 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $365 |
| Collegium Pharmaceutical, Inc. | 12 | $179 |
| Averitas Pharma Inc. | 6 | $154 |
| Lundbeck LLC | 6 | $136 |
| Saluda Medical Americas, Inc. | 4 | $111 |
| PFIZER INC. | 4 | $111 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| MML US, Inc. | 3 | $77 |
| Amgen Inc. | 3 | $61 |
| Globus Medical, Inc. | 2 | $44 |
Products named: BOTOX, Belbuca, QUTENZA, UBRELVY, VYEPTI, Evoke, NURTEC ODT, RELISTOR.
Industry payments across MD — which companies pay providers there.
